Linatil Comp (Enalapril Maleate, Hydrochlorothiazide)

Enalapril maleate blocks the angiotensin‑converting enzyme, which reduces the production of angiotensin II, a potent vasoconstrictor. This leads to relaxation of blood vessels, decreased aldosterone release, and ultimately lower blood pressure. The effect is complemented by hydrochlorothiazide’s diuretic action.

The dosage of Linatil Comp is individualized by the prescribing clinician based on the patient’s blood‑pressure profile, renal function, and response to therapy. The prescriber determines the appropriate strength and dosing schedule; patients should follow the exact instructions provided on the prescription label.

Linatil Comp is classified as pregnancy category D, indicating evidence of risk to the fetus. It should be avoided during pregnancy, especially in the second and third trimesters. Safety during breastfeeding has not been established, so the medication is generally not recommended for nursing mothers.

To request Linatil Comp, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Linatil Comp offers the convenience of a fixed‑dose combination of an ACE inhibitor and a thiazide diuretic, which can improve adherence compared with taking two separate tablets. Compared with monotherapy, the combination provides synergistic blood‑pressure reduction, but clinicians must consider individual tolerability and potential drug interactions.

Linatil Comp tablets should be stored at room temperature, below 25 °C, in their original blister pack or container. Protect them from excess moisture, direct sunlight and heat. Do not store in a refrigerator or freezer, and keep out of reach of children.

Linatil Comp is taken orally, usually once daily or as directed by the prescriber. The tablet should be swallowed whole with a full glass of water, and can be taken with or without food unless the prescribing information advises otherwise.

Serious risks include angioedema (swelling of the face, lips, tongue or airway), severe hypotension, acute kidney injury, and hyperkalaemia. Patients should seek immediate medical attention if they experience swelling, difficulty breathing, sudden dizziness, or a marked drop in blood pressure.

Linatil Comp is contraindicated in patients with a known hypersensitivity to enalapril, hydrochlorothiazide, or any component of the formulation. It should also be avoided in individuals with hereditary angioedema, severe renal impairment, or during pregnancy. Clinicians must evaluate each patient’s medical history before prescribing.